Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: Involvement of the p38 MAPK

Microbial Pathogenesis

Volumn 51, Issue 6, 2011, Pages 415-420

  Reddi, Durga ^a   Brown, Stuart J ^a,b   Belibasakis, Georgios N ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bone marrow stromal cells; Cyclooxygenase 2; Osteoprotegerin; P38 MAPK; Porphyromonas gingivalis; Receptor activator of nuclear factor kB ligand

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; BONE MARROW CELL; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DOWN REGULATION; GENE EXPRESSION REGULATION; MOLECULAR PATHOLOGY; NONHUMAN; OSTEOPROTEGERIN GENE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND GENE; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

ANIMALS; BONE MARROW; CELL LINE; CYCLOOXYGENASE 2; GENE EXPRESSION PROFILING; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PORPHYROMONAS GINGIVALIS; RANK LIGAND; STROMAL CELLS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PORPHYROMONAS GINGIVALIS;

EID: 80054841442     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.09.001     Document Type: Article

References (35)

1. Zambon J.J., Reynolds H.S., Slots J. Black-pigmented Bacteroides spp. in the human oral cavity. Infect Immun 1981, 32:198-203.
2. Reife R.A., Shapiro R.A., Bamber B.A., Berry K.K., Mick G.E., Darveau R.P. Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect Immun 1995, 63:4686-4694.
3. Malek R., Fisher J.G., Caleca A., Stinson M., van Oss C.J., Lee J.Y., et al. Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 1994, 176:1052-1059.
4. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003, 4:638-649.
5. Wong B.R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., et al. TRANCE is a Novel ligand of the tumor necrosis factor receptor family that Activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997, 272:25190-25194.
6. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
7. Yasuda H., Shima N., Nakagawa N., Mochizuki S.-I., Yano K., Fujise N., et al. Identity of osteoclastogenesis Inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998, 139:1329-1337.
8. Kong Y.-Y., Yoshida H., Sarosi I., Tan H.-L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
9. Udagawa N., Takahashi N., Jimi E., Matsuzaki K., Tsurukai T., Itoh K., et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 1999, 25:517-523.
10. Liu Y.-C.G., Lerner U.H., Teng Y.-T.A. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000, 52:163-206.
11. Udagawa N., Takahashi N., Jimi E., Matsuzaki K., Tsurukai T., Itoh K., et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 1999, 25:517-523.
12. Nakashima T., Kobayashi Y., Yamasaki S., Kawakami A., Eguchi K., Sasaki H., et al. Protein expression and functional difference of membrane-bound and Soluble receptor activator of NF-[kappa]B ligand: modulation of the expression by Osteotropic factors and cytokines. Biochem Biophys Res Commun 2000, 275:768-775.
13. Okahashi N., Inaba H., Nakagawa I., Yamamura T., Kuboniwa M., Nakayama K., et al. Porphyromonas gingivalis induces receptor activator of NF-{kappa}B ligand expression in osteoblasts through the activator protein 1 pathway. Infect Immun 2004, 72:1706-1714.
14. Belibasakis G.N., Bostanci N., Hashim A., Johansson A., Aduse-Opoku J., Curtis M.A., et al. Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. Microb Pathog 2007, 43:46-53.
15. Reddi D., Bostanci N., Hashim A., Aduse-Opoku J., Curtis M.A., Hughes F.J., et al. Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. Microbe Infect 2008, 10:1459-1468.
16. Belibasakis G.N., Reddi D., Bostanci N. Porphyromonas gingivalis Induces RANKL in T-cells. Inflammation 2011, 34:133-138.
17. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a Novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
18. Lerner U.H. New molecules in the tumor necrosis factor ligand and receptor superfamilies with importance for physiological and pathological bone resorption. Crit Rev Oral Biol Med 2004, 15:64-81.
19. Bennett A.M., Tonks N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997, 278:1288-1291.
20. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., Lee J.-D. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998, 395:713-716.
21. Cardone M.H., Salvesen G.S., Widmann C., Johnson G., Frisch S.M. The regulation of Anoikis: MEKK-1 activation requires cleavage by Caspases. Cell 1997, 90:315-323.
22. Oikawa A., Kobayashi M., Okamatsu Y., Shinki T., Kamijo R., Yamamoto M., et al. Mitogen-activated protein kinases mediate interleukin-1β-induced receptor activator of nuclear factor-κB ligand expression in human periodontal ligament cells. J Periodontal Res 2007, 42:367-376.
23. 2 production. Bone 2005, 36:267-275.
24. Chen, Chen, Lin Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 1999, 97:124-129.
25. Okahashi N., Sakurai A., Nakagawa I., Fujiwara T., Kawabata S., Amano A., et al. Infection by Streptococcus pyogenes induces the receptor activator of NF-κB ligand expression in mouse Osteoblastic cells. Infect Immun 2003, 71:948-955.
26. Rossa C., Ehmann K., Liu M., Patil C., Kirkwood K.L. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells. J Interferon Cytokine Res 2006, 10:719-729.
27. Walter C., Zahlten J., Schmeck B., Schaudinn C., Hippenstiel S., Frisch E., et al. Porphyromonas gingivalis strain-dependent activation of human endothelial cells. Infect Immun 2004, 72:5910-5918.
28. Zhang D., Zheng H., Zhao J., Lin L., Li C., Liu J., et al. Porphorymonas gingivalis induces intracellular adhesion molecule-1 expression in endothelial cells through the nuclear factor-kappaB pathway, but not through the p38 MAPK pathway. J Periodontal Res 2011, 46:31-38.
29. Watanabe K., Yilmaz O., Nakhjiri S.F., Belton C.M., Lamont R.J. Association of mitogen-activated protein kinase pathways with gingival Epithelial cell responses to Porphyromonas gingivalis. Infect Immun 2001, 69:6731-6737.
30. Mbalaviele G., Anderson G., Jones A., De Ciechi P., Settle S., Mnich S., et al. Inhibition of p38 mitogen-activated protein kinase Prevents inflammatory bone destruction. J Pharmacol Exp Ther 2006, 317:1044-1053.
31. Darveau R.P., Arbabi S., Garcia I., Bainbridge B., Maier R.V. Porphyromonas gingivalis lipopolysaccharide is both Agonist and Antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 2002, 70:1867-1873.
32. Rossa C., Liu M., Kirkwood K.L. A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-κB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide. J Periodontal Res 2008, 43:201-211.
33. Kikuchi T., Matsuguchi T., Tsuboi N., Mitani A., Tanaka S., Matsuoka M., et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like Receptors. J Immunol 2001, 166:3574-3579.
34. Rogers J.E., Li F., Coatney D.D., Otremba J., Kriegl J.M., Protter T.A., et al. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol 2007, 78:1992-1998.
35. Kirkwood K.L., Li F., Rogers J.E., Otremba J., Coatney D.D., Kreider J.M., et al. A p38alpha Selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther 2007, 320:56-63.